Key Success Criteria for Real-World Evidence (RWE) Studies


By Prof. Dr. Thomas Wilke, expert-trainer of the Generating RWE for Optimising Market/Patient Access course.

 

For a RWE study to be considered reliable and relevant to stakeholders in healthcare, policy, or scientific research it needs to meet several key criteria.

Key Success Criteria for Real-World Evidence (RWE) Studies

 

1. Stakeholder Acceptance

Gaining acceptance from key stakeholders is fundamental to the success of your RWE study. To achieve this:

  • Utilise Relevant Data: Source your data from real-world settings that accurately reflect the population and conditions under study. This enhances the applicability of your findings to practical scenarios.
  • Adhere to Reporting Standards: Follow established guidelines when reporting results. This transparency builds trust and credibility among stakeholders.
  • Align with Industry Expectations: Ensure your methodology and approach meet the standards set by regulatory bodies, healthcare professionals, and policymakers.
     

2. Scientific Credibility

Establishing scientific credibility is crucial for your study's impact and longevity:

  • Develop a Robust Protocol: Create a predefined study protocol that outlines your methodology and hypotheses before data collection begins. This proactive approach minimises bias and strengthens your study's foundation.
  • Pursue Peer Review: Seek peer review for your study. This external validation adds a layer of scrutiny and enhances your study's credibility in the scientific community.
  • Employ Rigorous Methodologies: Utilise state-of-the-art analytical techniques and tools to ensure your study stands up to scientific scrutiny.
     

3. Representativeness (External Validity)

Ensure your results are applicable beyond your study sample:

  • Enhance Generalisability: Design your study to produce results that can be extrapolated to broader target populations.
  • Focus on Real-World Applicability: Tailor your findings to be directly relevant to real-world clinical practice, making them valuable for healthcare providers and practitioners.
     

4. Internal Validity

Maintain the accuracy and reliability of your causal inferences:

  • Minimise Bias: In comparative analyses, implement robust methods to reduce bias, particularly when establishing causal relationships between interventions and outcomes.
  • Employ Advanced Statistical Techniques: Utilise sophisticated statistical methods to control for confounding factors and enhance the reliability of your results.
  • Conduct Sensitivity Analyses: Perform thorough sensitivity analyses to test the robustness of your findings under various assumptions.
     

5. Efficiency

Balance resource utilisation with research objectives:

  • Optimise Cost-Effectiveness: Develop strategies to achieve your research goals within a reasonable budget.
  • Prioritise Relevance: Focus on generating insights that are immediately applicable and valuable to decision-makers.
     

6. Risk Management

Prioritise ethical considerations and participant safety:

  • Minimise Participant Risk: Design your study to pose minimal additional risk to participants, especially when working with observational data from real-world settings.
  • Adhere to Ethical Standards: Ensure strict compliance with ethical guidelines and regulatory requirements.
  • Protect Individual Rights: Implement robust data protection measures and maintain transparency about data usage to safeguard participants' rights and privacy.

 

 

 

Subscribe to CELforPharma's newsletter to receive tips & insights from our expert faculty:

 

Please indicate your domains of interest:

Interested in domains

By subscribing to this newsletter, I accept the Privacy Policy.